INMED PHARMACEUTICALS INC

InMed Pharmaceuticals (INM) surged 8.27% to $1.44, adding 2.86% since last month. Explore its cannabis‑based biotech strategy, market cap, and trading data.

InMed Pharmaceuticals stock edges higher after a modest 1.5% gain, poised to ride growing cannabinoid‑therapy approvals and a diverse pipeline for pain and neurological disorders.

Explore InMed Pharmaceuticals: current $1.36 price, 52‑week upside, minor ADAR1 stake, and market dynamics for cannabinoid‑based biopharma investors.